1887

Abstract

Between January 2007 and April 2009, rotavirus (RV)-positive stool samples from 238 children with acute gastroenteritis, seen at Children’s Hospital of Michigan in Detroit, USA, were collected and RV genotyping was performed. G and P genotypes were determined by RT-PCR and nucleotide sequencing was conducted on selected G9 and P[6] strains. Correlation between the severity of gastroenteritis episode and the infecting G genotype was done using a 14-point scoring system. The predominant G genotype was G9 (39.5 %), followed by G1 (35.3 %) and G4 (15.5 %), while P[8] was the most prevalent P genotype (66.5 %), followed by P[4] (21.9 %) and P[6] (11.2 %). The gene combinations G1P[8] and G9P[8] were the most prevalent (21.4 % and 20.6 %, respectively), followed by G4P[8] (13 %) and G9P[6] (8.8 %). Immunization data showed that only 17/238 (7.1 %) children received ≥one dose of RV vaccine (the pentavalent vaccine RotaTeq or the monovalent vaccine Rotarix) and that 10/17 were infected with G4P[8] strains. Severity of RV gastroenteritis episodes was not related to the infecting G genotype. Our results suggest a high proportion of genotype G9 strains in combination with P[8], P[6] and P[4] specificity circulating in the metropolitan Detroit area. While the protective efficacy of the RV vaccines has been demonstrated against G9P[8] strains, the level of cross-protection offered by the vaccines against G9 strains with P[6] and P[4] genotypes in the Detroit paediatric population remains to be determined.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.026807-0
2011-06-01
2021-08-05
Loading full text...

Full text loading...

/deliver/fulltext/jmm/60/6/761.html?itemId=/content/journal/jmm/10.1099/jmm.0.026807-0&mimeType=html&fmt=ahah

References

  1. Abdel-Haq N. M., Thomas R. A., Asmar B. I., Zacharova V., Lyman W. D. 2003; Increased prevalence of G1P[4] genotype among children with rotavirus-associated gastroenteritis in metropolitan Detroit. J Clin Microbiol 41:2680–2682 [View Article][PubMed]
    [Google Scholar]
  2. Ansaldi F., Pastorino B., Valle L., Durando P., Sticchi L., Tucci P., Biasci P., Lai P., Gasparini R. et al. 2007; Molecular characterization of a new variant of rotavirus P[8]G9 predominant in a sentinel-based survey in central Italy. J Clin Microbiol 45:1011–1015 [View Article][PubMed]
    [Google Scholar]
  3. Araújo I. T., Ferreira M. S., Fialho A. M., Assis R. M., Cruz C. M., Rocha M., Leite J. P. 2001; Rotavirus genotypes P[4]G9, P[6]G9, and P[8]G9 in hospitalized children with acute gastroenteritis in Rio de Janeiro, Brazil. J Clin Microbiol 39:1999–2001 [View Article][PubMed]
    [Google Scholar]
  4. Aupiais C., de Rougemont A., Menager C., Vallet C., Brasme J. F., Kaplon J., Pothier P., Gendrel D. 2009; Severity of acute gastroenteritis in infants infected by G1 or G9 rotaviruses. J Clin Virol 46:282–285 [View Article][PubMed]
    [Google Scholar]
  5. Cascio A., Vizzi E., Alaimo C., Arista S. 2001; Rotavirus gastroenteritis in Italian children: can severity of symptoms be related to the infecting virus?. Clin Infect Dis 32:1126–1132 [View Article][PubMed]
    [Google Scholar]
  6. CDC 2008; Rotavirus surveillance – worldwide, 2001-2008. MMWR Morb Mortal Wkly Rep 57:1255–1257[PubMed]
    [Google Scholar]
  7. CDC 2010; Rotavirus vaccination coverage among infants aged 5 months – immunization information system sentinel sites, United States, June 2006-June 2009. MMWR Morb Mortal Wkly Rep 59:521–524[PubMed]
    [Google Scholar]
  8. Clark H. F., Hoshino Y., Bell L. M., Groff J., Hess G., Bachman P., Offit P. A. 1987; Rotavirus isolate WI61 representing a presumptive new human serotype. J Clin Microbiol 25:1757–1762[PubMed]
    [Google Scholar]
  9. Cunliffe N. A., Gondwe J. S., Graham S. M., Thindwa B. D., Dove W., Broadhead R. L., Molyneux M. E., Hart C. A. 2001; Rotavirus strain diversity in Blantyre, Malawi, from 1997 to 1999. J Clin Microbiol 39:836–843 [View Article][PubMed]
    [Google Scholar]
  10. de Rougemont A., Kaplon J., Lebon P., Huet F., Denis F., Alain S., Fourcade L., Grosjean J., El-Hajje M. J. et al. 2009; Unexpected substitution of dominant rotavirus G genotypes in French hospitalized children over five consecutive seasons. Eur J Clin Microbiol Infect Dis 28:403–407 [View Article][PubMed]
    [Google Scholar]
  11. de Rougemont A., Kaplon J., Pillet S., Mory O., Gagneur A., Minoui-Tran A., Meritet J. F., Mollat C., Lorrot M. et al. 2011; Molecular and clinical characterization of rotavirus from diarrheal infants admitted to pediatric emergency units in France. Pediatr Infect Dis J 30:118–124 [View Article][PubMed]
    [Google Scholar]
  12. Endara P., Trueba G., Solberg O. D., Bates S. J., Ponce K., Cevallos W., Matthijnssens J., Eisenberg J. N. 2007; Symptomatic and subclinical infection with rotavirus P[8]G9, rural Ecuador. Emerg Infect Dis 13:574–580 [View Article][PubMed]
    [Google Scholar]
  13. Esteban L. E., Rota R. P., Gentsch J. R., Jiang B., Esona M., Glass R. I., Glikmann G., Castello A. A. 2010; Molecular epidemiology of group A rotavirus in Buenos Aires, Argentina 2004-2007: reemergence of G2P[4] and emergence of G9P[8] strains. J Med Virol 82:1083–1093 [View Article][PubMed]
    [Google Scholar]
  14. Estes M. K., Kapikian A. Z. 2007; Rotaviruses. In Fields Virology pp. 1917–1974 Edited by Knipe D. M., Howley P. M. Philadelphia: Lippincott Williams & Wilkins;
    [Google Scholar]
  15. Gentsch J. R., Glass R. I., Woods P., Gouvea V., Gorziglia M., Flores J., Das B. K., Bhan M. K. 1992; Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 30:1365–1373[PubMed]
    [Google Scholar]
  16. Gentsch J. R., Laird A. R., Bielfelt B., Griffin D. D., Banyai K., Ramachandran M., Jain V., Cunliffe N. A., Nakagomi O. et al. 2005; Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis 192:Suppl. 1S146–S159 [View Article][PubMed]
    [Google Scholar]
  17. Gentsch J. R., Hull J. J., Teel E. N., Kerin T. K., Freeman M. M., Esona M. D., Griffin D. D., Bielfelt-Krall B. P., Banyai K. et al. 2009; G and P types of circulating rotavirus strains in the United States during 1996-2005: nine years of prevaccine data. J Infect Dis 200:Suppl. 1S99–S105 [View Article][PubMed]
    [Google Scholar]
  18. Gouvea V., Glass R. I., Woods P., Taniguchi K., Clark H. F., Forrester B., Fang Z. Y. 1990; Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 28:276–282[PubMed]
    [Google Scholar]
  19. Gurgel R. Q., Cuevas L. E., Vieira S. C., Barros V. C., Fontes P. B., Salustino E. F., Nakagomi O., Nakagomi T., Dove W. et al. 2007; Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg Infect Dis 13:1571–1573[PubMed] [CrossRef]
    [Google Scholar]
  20. Iturriza-Gómara M., Green J., Brown D. W., Ramsay M., Desselberger U., Gray J. J. 2000; Molecular epidemiology of human group A rotavirus infections in the United Kingdom between 1995 and 1998. J Clin Microbiol 38:4394–4401[PubMed]
    [Google Scholar]
  21. Iturriza-Gómara M., Kang G., Gray J. 2004; Rotavirus genotyping: keeping up with an evolving population of human rotaviruses. J Clin Virol 31:259–265 [View Article][PubMed]
    [Google Scholar]
  22. Koshimura Y., Nakagomi T., Nakagomi O. 2000; The relative frequencies of G serotypes of rotaviruses recovered from hospitalized children with diarrhea: a 10-year survey (1987-1996) in Japan with a review of globally collected data. Microbiol Immunol 44:499–510[PubMed] [CrossRef]
    [Google Scholar]
  23. Laird A. R., Gentsch J. R., Nakagomi T., Nakagomi O., Glass R. I. 2003; Characterization of serotype G9 rotavirus strains isolated in the United States and India from 1993 to 2001. J Clin Microbiol 41:3100–3111 [View Article][PubMed]
    [Google Scholar]
  24. Leite J. P., Alfieri A. A., Woods P. A., Glass R. I., Gentsch J. R. 1996; Rotavirus G and P types circulating in Brazil: characterization by RT-PCR, probe hybridization, and sequence analysis. Arch Virol 141:2365–2374 [View Article][PubMed]
    [Google Scholar]
  25. Martella V., Terio V., Arista S., Elia G., Corrente M., Madio A., Pratelli A., Tempesta M., Cirani A., Buonavoglia C. 2004; Nucleotide variation in the VP7 gene affects PCR genotyping of G9 rotaviruses identified in Italy. J Med Virol 72:143–148 [View Article][PubMed]
    [Google Scholar]
  26. Parashar U. D., Hummelman E. G., Bresee J. S., Miller M. A., Glass R. I. 2003; Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 9:565–572[PubMed] [CrossRef]
    [Google Scholar]
  27. Parashar U. D., Gibson C. J., Bresse J. S., Glass R. I. 2006; Rotavirus and severe childhood diarrhea. Emerg Infect Dis 12:304–306[PubMed] [CrossRef]
    [Google Scholar]
  28. Perez-Schael I., Blanco M., Vilar M., Garcia D., White L., Gonzalez R., Kapikian A. Z., Flores J. 1990; Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants. J Clin Microbiol 28:553–558[PubMed]
    [Google Scholar]
  29. Ramachandran M., Gentsch J. R., Parashar U. D., Jin S., Woods P. A., Holmes J. L., Kirkwood C. D., Bishop R. F., Greenberg H. B. et al. 1998; Detection and characterization of novel rotavirus strains in the United States. J Clin Microbiol 36:3223–3229[PubMed]
    [Google Scholar]
  30. Ramachandran M., Kirkwood C. D., Unicomb L., Cunliffe N. A., Ward R. L., Bhan M. K., Clark H. F., Glass R. I., Gentsch J. R. 2000; Molecular characterization of serotype G9 rotavirus strains from a global collection. Virology 278:436–444 [View Article][PubMed]
    [Google Scholar]
  31. Rodrigues F., Iturriza M., Gray J., Januário L., Lemos L. 2007; Epidemiology of rotavirus in Portugal: G9 as a major cause of diarrhoea in non-hospitalised children. J Clin Virol 40:214–217 [View Article][PubMed]
    [Google Scholar]
  32. Ruiz-Palacios G. M., Pérez-Schael I., Velázquez F. R., Abate H., Breuer T., Clemens S. C., Cheuvart B., Espinoza F., Gillard P. et al. 2006; Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354:11–22 [View Article][PubMed]
    [Google Scholar]
  33. Samajdar S., Ghosh S., Chawla-Sarkar M., Mitra U., Dutta P., Kobayashi N., Naik T. N. 2008; Increase in prevalence of human group A rotavirus G9 strains as an important VP7 genotype among children in eastern India. J Clin Virol 43:334–339 [View Article][PubMed]
    [Google Scholar]
  34. Sánchez-Fauquier A., Montero V., Moreno S., Solé M., Colomina J., Iturriza-Gomara M., Revilla A., Wilhelmi I., Gray J. Gegavi/VIGESS-Net Group 2006; Human rotavirus G9 and G3 as major cause of diarrhea in hospitalized children, Spain. Emerg Infect Dis 12:1536–1541[PubMed] [CrossRef]
    [Google Scholar]
  35. Santos N., Hoshino Y. 2005; Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 15:29–56 [View Article][PubMed]
    [Google Scholar]
  36. Santos N., Volotão E. M., Soares C. C., Albuquerque M. C., da Silva F. M., de Carvalho T. R., Pereira C. F., Chizhikov V., Hoshino Y. 2001; Rotavirus strains bearing genotype G9 or P[9] recovered from Brazilian children with diarrhea from 1997 to 1999. J Clin Microbiol 39:1157–1160 [View Article][PubMed]
    [Google Scholar]
  37. Santos N., Volotão E. M., Soares C. C., Campos G. S., Sardi S. I., Hoshino Y. 2005; Predominance of rotavirus genotype G9 during the 1999, 2000, and 2002 seasons among hospitalized children in the city of Salvador, Bahia, Brazil: implications for future vaccine strategies. J Clin Microbiol 43:4064–4069 [View Article][PubMed]
    [Google Scholar]
  38. Steele A. D., Ivanoff B. 2003; Rotavirus strains circulating in Africa during 1996-1999: emergence of G9 strains and P[6] strains. Vaccine 21:361–367 [View Article][PubMed]
    [Google Scholar]
  39. Velázquez F. R., Matson D. O., Calva J. J., Guerrero L., Morrow A. L., Carter-Campbell S., Glass R. I., Estes M. K., Pickering L. K., Ruiz-Palacios G. M. 1996; Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 335:1022–1028 [View Article][PubMed]
    [Google Scholar]
  40. Vesikari T., Matson D. O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., Dallas M. J., Heyse J. F., Goveia M. G. et al. 2006; Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354:23–33 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.026807-0
Loading
/content/journal/jmm/10.1099/jmm.0.026807-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error